Ocutrx Tech (June 2025)

Improving Lives Through Innovation

© 2025

Technology Development

MEDICAL DEVICES

Contract Manufacturing

SATELLITE

OCULENZ FOR AMD Q3 2025

OCULENZ SDK & DIGILOUPES Q4 2026

OR-BOT + ORLENZ AR & LIGHTFIELD3D MONITOR Q1 2028

Additional development for non-medical (ADNOC, etc.)

AEROSPACE

COMMERCIAL

Patient #1 • Brigadier General Richard Freeman was used to flying fighter jets at Mach 2. He was also an inventor and entrepreneur.

Patient #1

• Gen. Freeman was diagnosed with Advanced Macular Degeneration and could no longer fly, drive, manage his business or see his grandchildren.

• Unable to accept his life without vision, he challenged his sons to find a way to fix this dreadful disease.

4

Founders •

Brothers Michael and Mitch Freeman Invented “streaming mobile video” in the 90s, which became foundation for IEEE 802.11(n) MIMO standards.

•

The Freemans old their technology and IP to Samsung in the 2000s – which is still is used when we send videos, use Facetime, Zoom, and 4G

•

100+ combined patents in several scientific fields

•

Founded Ocutrx to correct their father’s AMD and ended up finding the solution to many problems faced by AR companies.

Michael Freeman CEO/CTO

Mitchael Freeman COO

FORTHCOMING PRODUCTS

1

2

3

OcuLenz for Low-Vision Patients

DigiLoupes for Surgeons

OR-Bot Surgery Visualization Theatre for Surgeons

What’s the problem?

Advanced Macular Degeneration (AMD) is a central vision disease affecting 200 million worldwide – and growing exponentially.

NORMAL VISION

EARLY AMD

INTERMEDIATE AMD

ADVANCED AMD

Macu

“Not only am I losing everything for myself, but I am also becoming a burden to my family & friends.”

-Linda, AMD patient

8

The Solution:

•Lightest weight and tetherless •Indoor & outdoor use •Widest field-of-view •Patented hardware and software •SaaS allows communication with doctor •Wifi and cellular connectivity •Offers magnification, contrast adjustment, and streaming text. Restores user independence •Relinquishes caretaker responsibility

Commercialization scheduled late 2025

Another Problem:

Traditional Loupes used by surgeons • Unergonomic: Traditional Loupes are unergonomic, and cause Surgeons to need neck and back surgery themselves, some being forced to retire early.

• Analog: Fixed magnification, no connectivity options; not digital • Costly: Ranging in price from $1,500 to $10,000. Surgeons often have multiple pairs.

Traditional Optical Loupes for medical & non-medical applications

The Solution:

✓ Optimized Ergonomics ✓ Adjustable Magnification ✓ All Digital

Unique Features Self Contained: Wireless, tetherless, and handsfree. Hot swap battery allows battery to be changed without disrupting surgery feed.

Cinematic View: 5K and 8K resolution. Widest Field-of-View.

3D stereoscopic imaging.

All Digital: 5G, Wi-Fi, and Bluetooth connectivity, allowing for telesurgery.

Adjustable Magnification: Up to 20x adjustable zoom for unprecedented visualization of surgery site.

Ergonomic. Downward-facing cameras allow the surgeon to look forward while the headset looks down.

14

Problems in the OR • Poor Ergonomics • Space Constrains • Inferior Resolution

14

The Solution…

OR-Bot LightField3D Holographic Microscope Surgery System with 2 unique viewing options.

Unique Features

Visualization Option: Lightfield3D Holographic Monitors one for the surgeon one for nurses, techs, students

Visualization Option: OcuLenz AR Headset 5K resolution 120 degrees field-of-view

LightField3D Holographic Microscope 240x magnification

ORLenz® AR/XR Headset

Commercialization Timeline

Q1 & Q2 2025

Q3 2025

Q1 2026

Q4 2026

Q1 2027

Q4 2027

OcuLenz Patient Tests & Final Development

OcuLenz for AMD Launch in USA

DigiLoupes FDA Trials

DigiLoupes Launch in USA

OR-Bot FDA Trials

OR-Bot Launch in USA

19

Manufacturing Subsidiary

Manufacturing Division Spectrum AMT is a 28-year-old microelectronics manufacturer; purchased by Ocutrx in 2023.

Capabilities: • High-Reliability Circuit Card Assembly • Electronic Systems & Assemblies • Wiring & Harnessing • Conformal Coating • Environmental Testing • Satellite Bus builds Industries we serve: • Spaceflight • Aerospace • DoD & NATO • Medical Devices • Enterprise & Industrial

Customers

Analog Devices, Inc. Air Force Academy (USAF) Air Force Research Laboratory Aspen Microsystems ATS Energy Avanti Circuits, Inc. BAE Systems, Inc. Ball Aerospace Blue Canyon Technologies Blue Origin Space Blue Line Engineering Boeing Corporation Broadcom Limited CACI International, Inc. D-Orbit USA Design Sciences, Inc. Defense Logistics Agency Dynetics Corporation Department of Defense (UIS)

Fluke Corporation Geneva Technologies, Inc. Global Comms Exchange, Inc. General Atomics Honeybee Robotics, Ltd. Iris Technology In Track Radar Technologies, Inc. iSpace Technologies US, Inc. Jet Propulsion Labs (JPL) NASA Kaman Space and Defense Keysight Technologies L3 Harris, Inc. Linear Automation Lockheed Martin Corp MIT Lincoln Labs NASA NASA (Goddard Space Flight Center) NATO Northrop Grumman

Raytheon, Inc. Rockwell Automation Royal Australian Navy Sandia National Laboratories Sanmina-SCI Corporation Scientific Applications & Research Associates, Inc. (SARA) SECOTEC, Inc. SemQuest, Inc. Sierra Space Corporation SAIC US Space Development Agency Teledyne FLIR Trident Vantage Systems, LLC ThermoFisher Scientific United Launch Alliance, LLC US Navy Crane IUADP Welkin Sciences, LLC Western Digital Technologies And more…

22

Profit & Loss Space & Microelectronics

$18

$13.9

Revenue Expenses EBITDA

$13.5

$12.7 $11.5

$10.2

$10.3

$7.1

*in millions

$6.3

$7.9

$6.1

$6.1

$2.9

$1

$4.4

$4.2 $1.2

$1.8

2020

2021

2022

2023

2024

2025 expected

23

Traction

• 70+ employees • Employee longevity (18 years+) • Commitment to Quality Manufacturing Instructors: • NASA-STD-8739.1 Level B Instructor • IPC/WHAM-A-620 BS Instructor • IPC/J-STD-001 GS Instructor

Satellite Expansion • Potential for over 1,000 satellite assemblies.

• Each satellite produces $1M-$2.5M in revenue.

• Potential revenue increase of over $1B over next 5 years.

• 40+ Employees & Consultants • 50+ Medical Advisory Board Members • 5 PhD, +20 Masters Level employees • IEEE Senior Fellows • 1 SPIE Senior Fellow Offices: • Laguna Beach, California, USA • Tulsa, Oklahoma, USA • Frankfurt, Germany • Dubai, UAE

80% of Ocutrx investors are surgeons who need our solutions.

50+ surgeons on our medical advisory boards.

Partnerships in our pipeline

Strategic Partners in negotiation

Intellectual Property

39 116 $85-$100M

Issued patents.

Pending Patents.

In several different patent families.

2025 Patent Portfolio Valuation.

30

Financials

Previous & Future Funding You Are Here Map Pointer - Vector Illustration Isolated On White Background You Are Here Map Pointer - Vector Illustration - Isolated On White Background you are here sign stock illustrations

WE ARE HERE

Equity Raised:

Debt Acquired:

$19M

$25M acquisition of Spectrum

Round C:

$50M @ $3.00 per share

32

Use of Capital: $50M USD G&A, Patents, Clinical trials, Marketing, Fees, Infrastructure Expansion, Etc.

Commercialization of Medical Devices

$20M

$18M

UAE Expansion

$5M

Spectrum AMT: Satellite Expansion & CapEx

$7M

Pro Forma Ocutrx & Spectrum Consolidated 2025

2026

2027

2028

2029

Total Revenue

$21M

$46M

$159M

$254M

$370M

COGS

$9M

$17M

$50M

$82M

$120M

Gross Profit

$11M

$29M

$109N

$172M

$250M

Operating Cost

$5M

$10M

$28N

$43M

$61M

EBITDA

$6M

$19M

$80M

$129M

$188M

Expected Dividends

Estimated Dividends per share Estimated Dividends paid Total Estimated Dividends

* Assumes a $50M investment for the purchase of 16,666,667 shares

2027 $0.31 $5.2M

2028 2029 $0.81 $1.41 $13.4M $23.4M $42M

Exit Potentials

PRIVATE SALE

IPO Estimated 2029 EBITDA Estimated EBITDA Multiple Estimated Market Value of Company Round C Investor Stock Value Price per Share

$188M 15x $2.8B $480M $28.80

36

Investment Opportunity

The Opportunity

$50M USD $3.00 16,666,667 17% $100K

ROUND C PER SHARE SHARES OF THE COMPANY

MINIMUM INVESTMENT

One Investment; two companies.

1

Compelling investment profile with natural hedge: • High-growth innovation company

• Established, revenue-generating manufacturing business.

2

Emerging technology company, developing medical devices for patients and surgeons.

28-year-old manufacturing facility of advanced electronics with multiyear contracts.

Additional Resources

39

Click to Learn More MEDTILES DIGITAL OVERLAY A satellite in space above earth Description automatically generated

OcuLenz Patient Trial Video

ORLenz features MedTiles Video

Spectrum’s Capabilities Video 40

41

Thank you.

For more information: Victoria McArtor Chief Communications Officer Victoria.mcartor@ocutrxtech.com +19186970494 41